Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Schlieren
State: Zurich
Zip:
Country: Switzerland
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Series A | $0 |
Aglaia BioMedical Ventures M Ventures Novo Holdings Aglaia BioMedical Ventures M Ventures Novo Holdings |
6/2018 | Series A | $0 |
Aglaia BioMedical Ventures M Ventures Novo Holdings Aglaia BioMedical Ventures M Ventures Novo Holdings |
12/2015 | Seed Round | $0 |
Aglaia BioMedical Ventures EVA Basel Microsoft Accelerator Novo Holdings Aglaia BioMedical Ventures EVA Basel Microsoft Accelerator Novo Holdings |
6/2018 | Series A | 3 | $5.5M |
Aglaia BioMedical Ventures M Ventures Novo Holdings Aglaia BioMedical Ventures M Ventures Novo Holdings |
5/2017 | Series A | 3 | $10.8M |
Aglaia BioMedical Ventures M Ventures Novo Holdings Aglaia BioMedical Ventures M Ventures Novo Holdings |
12/2015 | Seed Round | 4 | $3.7M |
Aglaia BioMedical Ventures EVA Basel Microsoft Accelerator Novo Holdings Aglaia BioMedical Ventures EVA Basel Microsoft Accelerator Novo Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|